ADAMAS PHARMACEUTICALS INC's ticker is ADMS and the CUSIP is 00548A106. A total of 117 filers reported holding ADAMAS PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is 0.28 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2021 | $93,000 | -66.3% | 17,561 | -69.5% | 0.00% | -100.0% |
Q1 2021 | $276,000 | +60.5% | 57,484 | +44.4% | 0.00% | +100.0% |
Q4 2020 | $172,000 | -49.3% | 39,822 | -51.7% | 0.00% | -80.0% |
Q3 2020 | $339,000 | +1203.8% | 82,363 | +721.4% | 0.01% | – |
Q2 2020 | $26,000 | -77.2% | 10,027 | -66.8% | 0.00% | -100.0% |
Q4 2019 | $114,000 | -7.3% | 30,177 | +52.4% | 0.00% | 0.0% |
Q2 2019 | $123,000 | -41.7% | 19,803 | -19.9% | 0.00% | -50.0% |
Q4 2018 | $211,000 | -79.9% | 24,720 | -52.8% | 0.00% | -84.6% |
Q3 2018 | $1,049,000 | -68.7% | 52,400 | -59.7% | 0.01% | -70.5% |
Q2 2018 | $3,355,000 | +301.3% | 129,874 | +271.2% | 0.04% | +238.5% |
Q1 2018 | $836,000 | +8.0% | 34,992 | +53.3% | 0.01% | 0.0% |
Q4 2017 | $774,000 | +223.8% | 22,828 | +102.1% | 0.01% | +160.0% |
Q3 2017 | $239,000 | – | 11,296 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Stonepine Capital Management, LLC | 1,423,578 | $8,826,000 | 6.08% |
Healthcare Value Capital, LLC | 200,000 | $1,240,000 | 2.33% |
ARMISTICE CAPITAL, LLC | 2,700,000 | $16,740,000 | 1.06% |
DELTEC ASSET MANAGEMENT LLC | 550,836 | $3,415,000 | 0.75% |
Broadfin Capital, LLC | 441,088 | $2,735,000 | 0.60% |
Kerrisdale Advisers, LLC | 229,347 | $1,422,000 | 0.51% |
Worth Venture Partners, LLC | 87,908 | $545,000 | 0.30% |
Mosaic Family Wealth, LLC | 91,314 | $566,000 | 0.24% |
EMERALD ADVISERS, LLC | 700,176 | $4,341,000 | 0.17% |
EMERALD MUTUAL FUND ADVISERS TRUST | 616,664 | $3,823,000 | 0.15% |